Ropes & Gray represented Davidson Kempner Capital Management and Highbridge Capital Management in a convertible note exchange and purchase transaction with biotech company, Biora Therapeutics Inc., reducing Biora’s debt by 60%, coupled with a maturity extension and the provision of $16.7 million in new capital to Biora. The transaction was announced in a December 18 press release.
Davidson Kempner Capital Management is a global investment management firm with over 40 years of experience and a focus on fundamental investing with a multi-strategy approach.
Highbridge Capital Management is a global alternative investment firm offering credit and volatility focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles, and co-investments.
This team was led by capital solutions & private credit partners Sam Badawi and Alyson Gal and IP transactions partner Melissa Rones.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.